Bioanalytical Methods for Poly(ADP-Ribose) Polymerase Inhibitor Quantification: A Review for Therapeutic Drug Monitoring

Therapeutic drug monitoring (TDM) of poly(ADP-ribose) polymerase inhibitors (PARPis) is an exploratory practice aimed at improving the quality of treatment through personalized therapy. Currently, there are 4 European Medicines Agency-approved and US Food and Drug Administration–approved PARPis avai...

Descripción completa

Detalles Bibliográficos
Autores principales: Orleni, Marco, Canil, Giovanni, Posocco, Bianca, Gagno, Sara, Toffoli, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Therapeutic Drug Monitoring 2023
Materias:
Focus Series: Therapeutic Drug Monitoring in Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10168115/
https://www.ncbi.nlm.nih.gov/pubmed/36728223
http://dx.doi.org/10.1097/FTD.0000000000001081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10168115/
https://www.ncbi.nlm.nih.gov/pubmed/36728223
http://dx.doi.org/10.1097/FTD.0000000000001081

Ejemplares similares